GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » Shiller PE Ratio

uniQure NV (FRA:UQ1) Shiller PE Ratio : (As of May. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is uniQure NV Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


uniQure NV Shiller PE Ratio Historical Data

The historical data trend for uniQure NV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

uniQure NV Shiller PE Ratio Chart

uniQure NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

uniQure NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of uniQure NV's Shiller PE Ratio

For the Biotechnology subindustry, uniQure NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


uniQure NV's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, uniQure NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where uniQure NV's Shiller PE Ratio falls into.



uniQure NV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

uniQure NV's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, uniQure NV's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.403/126.4000*126.4000
=-1.403

Current CPI (Dec. 2023) = 126.4000.

uniQure NV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.517 99.390 -0.657
201406 -0.512 99.240 -0.652
201409 -0.502 99.960 -0.635
201412 -0.775 99.050 -0.989
201503 -0.690 99.750 -0.874
201506 -0.869 100.230 -1.096
201509 -1.083 100.500 -1.362
201512 -0.636 99.730 -0.806
201603 -0.808 100.310 -1.018
201606 -0.748 100.260 -0.943
201609 -0.544 100.570 -0.684
201612 -0.550 100.710 -0.690
201703 -0.748 101.440 -0.932
201706 -0.739 101.370 -0.921
201709 -0.336 102.030 -0.416
201712 -0.769 101.970 -0.953
201803 -0.478 102.470 -0.590
201806 -0.488 103.100 -0.598
201809 -0.506 103.950 -0.615
201812 -0.519 103.970 -0.631
201903 -0.655 105.370 -0.786
201906 -0.735 105.840 -0.878
201909 -0.527 106.700 -0.624
201912 -0.873 106.800 -1.033
202003 -0.570 106.850 -0.674
202006 -0.852 107.510 -1.002
202009 -1.027 107.880 -1.203
202012 -0.008 107.850 -0.009
202103 -0.764 108.870 -0.887
202106 7.063 109.670 8.140
202109 -0.672 110.790 -0.767
202112 0.150 114.010 0.166
202203 -0.908 119.460 -0.961
202206 -0.795 119.050 -0.844
202209 -1.030 126.890 -1.026
202212 0.142 124.940 0.144
202303 -1.522 124.720 -1.543
202306 -1.329 125.830 -1.335
202309 -1.762 127.160 -1.751
202312 -1.403 126.400 -1.403

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


uniQure NV  (FRA:UQ1) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


uniQure NV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of uniQure NV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


uniQure NV (FRA:UQ1) Business Description

Traded in Other Exchanges
Address
Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

uniQure NV (FRA:UQ1) Headlines

No Headlines